Histotripsy for Ablation of Liver Tumours in Asia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Histotripsy for Ablation of Liver Tumours in Asia — Stella

Recruiting

Back to Liver Malignant Tumors trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Singapore

National University Hospital, Singapore

National Cancer Centre Singapore, Singapore

Singapore General Hospital, Singapore

Key details

Sponsor

National Cancer Centre, Singapore

Enrollment target

~40 participants

Started

November 2025

Primary completion

November 2027

Age range

21 Years – 99 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov